Menu Search
Equities

Tecan Group AG

TECN:SWX

Tecan Group AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)213.80
  • Today's Change-2.80 / -1.29%
  • Shares traded50.76k
  • 1 Year change-21.57%
  • Beta0.9912
Data delayed at least 15 minutes, as of Nov 13 2024 16:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform5
Hold4
Sell0
Strong Sell0

Share price forecast in CHF

The 8 analysts offering 12 month price targets for Tecan Group AG have a median target of 279.00, with a high estimate of 384.00 and a low estimate of 241.00. The median estimate represents a 28.81% increase from the last price of 216.60.
High77.3%384.00
Med28.8%279.00
Low11.3%241.00

Dividends in CHF

In 2023, Tecan Group AG reported a dividend of 3.00 CHF, which represents a 3.45% increase over last year. The 8 analysts covering the company expect dividends of 2.45 CHF for the upcoming fiscal year, a decrease of 18.20%.
Div growth (TTM)3.45%
More ▼

Earnings history & estimates in CHF

Tecan Group AG reported annual 2023 earnings of 10.30 per share on Mar 12, 2024.
Average growth rate+14.96%
More ▼

Revenue history & estimates in CHF

Tecan Group Ltd. had revenues for the full year 2023 of 1.07bn. This was 6.11% below the prior year's results.
Average growth rate+14.77%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.